Interacting Drugs |
Butalbital compound and codeine vs Ticagrelor |
Security Level |
 |
Mechanism |
Ticagrelor: Aspirin may enhance the antiplatelet effect of Ticagrelor. Aspirin may diminish the therapeutic effect of Ticagrelor. More specifically, the benefits of ticagrelor relative to clopidogrel may be diminished in patients receiving daily aspirin doses greater than 100-150 mg daily. |
Management |
Avoid daily aspirin doses greater than 100 mg in patients receiving ticagrelor. Canadian recommendations are to avoid daily aspirin doses greater than 150 mg. Daily low-dose aspirin (U.S.: 75-100 mg; Canada: 75-150 mg) is recommended. |
Butalbital compound and codeine vs Ticagrelor
Post Review about Butalbital compound and codeine vs Ticagrelor Click here to cancel reply.
Other Interactions of Butalbital compound and codeine
Other Interactions of Ticagrelor
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.